期刊文献+

反相高效液相色谱法测定氟非尼酮的含量

RP-HPLC determination of fluorofenidone
原文传递
导出
摘要 目的:建立测定氟非尼酮含量的高效液相色谱法。方法:采用Waters Symmetry C18柱(250 mm×4.6 mm,5μm);流动相为乙腈-0.1%三乙胺水溶液(40∶60,磷酸调至pH 4.0),流速:1.0 mL·min-1,检测波长:310 nm,柱温:35℃。结果:氟非尼酮的浓度在5~1000μg·mL-1范围内线性良好(r=0.9997);方法的最低检测限为5 ng(S/N=3);高、中、低3个浓度的平均回收率(n=5)分别为99.7%(RSD=0.23%),101.7%(RSD=0.19%),100.3%(RSD=0.12%);各杂质峰与主峰达到基线分离。结论:此方法操作简便、灵敏、准确,重复性好,适用于氟非尼酮的含量测定,可作为该药质量控制的检测方法。 Objective: To establish an RP-HPLC method for determination of the content of fluorofenidone.Methods: The column was Waters Symmetry C18(250 mm×4.6 mm,5 μm),the mobile phase consisted of acetonitrile-0.1% triethylamine solution(40∶60) with a flow rate of 1.0 mL·min-1,the UV detection wavelength was set at 310 nm.Results:The calibration curve was linear within the range of 5 to 1000 μg·mL-1(r=0.9997);the lowest limit determination was 5 ng(S/N =3).The mean recoveries(n=5) of high,middle and low concentration were 99.7%(RSD=0.23%),101.7%(RSD=0.19%),100.3%(RSD=0.12%);the chromatographic peaks of fluorofenidone and its related substances were well isolated.Conclusion:The method is simple,selective,accurate and reproducible.It is suitable for determination of the content of fluorofenidone.
出处 《药物分析杂志》 CAS CSCD 北大核心 2011年第4期776-778,共3页 Chinese Journal of Pharmaceutical Analysis
关键词 反相高效液相色谱法 氟非尼酮 含量测定 RP-HPLC fluorofenidone assay
  • 相关文献

参考文献7

  • 1TAOLi-jian(陶立坚) ZHANGJun(张军) HUGao-yun(胡高云) etal.Effects of 1-(3-fluorophenyl)-5-methyl-2-(1H)-pyridone on renal fibroblast in rats[1-(3-氟苯基]-5-甲基-2-(1H)吡啶酮对鼠肾成纤维细胞的影响][J].J Cent South Univ (Med Sci),2004,29(2):139-139. 被引量:1
  • 2李萍,陶立坚,胡国龄,谭德明.1-(3-氟苯基)-5-甲基-2-(1H)吡啶酮对肝星状细胞的影响[J].中国临床药理学与治疗学,2007,12(7):782-785. 被引量:5
  • 3PENG Zhang-zhe,HU Gao-yun,SHEN Hong,et al.Fluorofenidone attenuates collagen I and transforming growth factor-β1 expression through a nicotinamide adenine dinucleotide phosphate oxidase-dependent way in NRK-52E cells.Nephrology.2009,14:565. 被引量:1
  • 4WANG Ling,HU Gao-yun,SHEN Hong,et al.Fluorofenidone inhibits TGF-b1 induced CTGF via MAPK pathways in mouse mesangial cells.Pharmazie,2009,64:680. 被引量:1
  • 5Nagai S,Hamada K,Shigematsu M,et al.Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis.Intern Med,2002,41 (12):1118. 被引量:1
  • 6Azuma A,Nukiwa T,Tsuboi E,et al.Double-blind,placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med,2005,171(9):1040. 被引量:1
  • 7Dosanjh A,Ikonen T,Wan B, et al.Pirfenidone:A novel anti-fibrotic agent and progressive chronic allograft rejection.Pulm Pharmacol Ther,2002,15 (5):433. 被引量:1

二级参考文献16

  • 1Friedman SL.Molecular regulation of hepatic fibrosis,an integrated cellular response to tissue injury[J].J Biol Chem,2000;275:2247-2250. 被引量:1
  • 2Friedman SL,Maher JJ,Bissel M.Mechanisms and therapy of hepatic fibrosis:report of the AASLD single topic basic research conference[J].Hepatology,2000;32:1403-1408. 被引量:1
  • 3Card JW,Racz WJ,Brien JF,et al.Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity[J].Toxicol Sci,2003;75:169-180. 被引量:1
  • 4Giri SN,Al-Bayati MA,Du X,et al.Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats[J].Cancer Chemother Pharmacol,2004;53:141-150. 被引量:1
  • 5Tsuchiya H,Kaibori M,Yanagida H,et al.Pirfenidone prevents endotoxin-induced liver injury after partial hepatectomy in rats[J].J Hepatol,2004;40:94-101. 被引量:1
  • 6Iyer SN,Wild JS,Schiedt MJ,et al.Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters[J].J Lab Clin Med,1995;125:779-785. 被引量:1
  • 7Shimizu T,Fukagawa M,Kuroda T,et al.Pirfenidone prevents collagen accumulation in the remnant kidney in rats with partial nephrectomy[J].Kidney Int Suppl,1997;52:S239-S243. 被引量:1
  • 8Shimizu T,Kuroda T,Hata S,et al.Pirfenidone improves renal function and fibrosis in the postobstructed kidney[J].Kidney Int,1998;54:99-109. 被引量:1
  • 9Suga H,Teraoka S,Ota K,et al.Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats[J].Exp Toxicol Pathol,1995;47:287-291. 被引量:1
  • 10Iyer SN,Gurujeyalakshmi G,Giri SN.Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis[J].J Pharmacol Exp Ther,1999;289:211-218. 被引量:1

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部